Cargando…
Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation
BACKGROUND: Chondrosarcoma is characterized for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and low rates of survival. Research within the field of development and expansion of new treatment options for unresectable or metastatic diseases i...
Autores principales: | Lohberger, Birgit, Leithner, Andreas, Stuendl, Nicole, Kaltenegger, Heike, Kullich, Werner, Steinecker-Frohnwieser, Bibiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641423/ https://www.ncbi.nlm.nih.gov/pubmed/26555773 http://dx.doi.org/10.1186/s12885-015-1915-4 |
Ejemplares similares
-
Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes
por: Steinecker-Frohnwieser, Bibiane, et al.
Publicado: (2017) -
The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy
por: Lohberger, Birgit, et al.
Publicado: (2016) -
Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
por: Lohberger, Birgit, et al.
Publicado: (2022) -
Sesquiterpene Lactones Downregulate G2/M Cell Cycle Regulator Proteins and Affect the Invasive Potential of Human Soft Tissue Sarcoma Cells
por: Lohberger, Birgit, et al.
Publicado: (2013) -
Nuclear Magnetic Resonance Therapy Modulates the miRNA Profile in Human Primary OA Chondrocytes and Antagonizes Inflammation in Tc28/2a Cells
por: Steinecker-Frohnwieser, Bibiane, et al.
Publicado: (2021)